Reporter brief
Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation &Amp;Amp;Amp;Amp; Metabolic Rate
What happened
Trial registry update: RECRUITING. No results reported in the supplied registry record.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- This abstract reports only the study protocol and eligibility criteria, not outcomes or findings, so no conclusions about efficacy can be drawn. The study was designed to test NR in healthy volunteers only, not in the diabetic participants, limiting generalizability to people with metabolic disease. Whether any observed changes in fat oxidation or metabolic rate translate to clinically meaningful benefits for fatty liver disease or weight management is not addressed.
Study design and sample
Rct; Human.
Healthy volunteers (men aged 18-65, women aged 18-50, BMI ≥25) and adults with MODY2 (maturity-onset diabetes of the young type 2)
- Design
- Rct
- Sample
- —
- Journal
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Published
- Sep 18, 2026
Effect size
Not recorded.
Caveats
- Assessment: Unassessed.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Previous evidence
See the Nicotinamide riboside timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.